Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Journal of Surgical Oncology
|
August 1, 1992
Retroperitoneal surgery in patients with nonseminomatous testicular cancer and minimal residual tumor
H Qvist, S D Fosså, S Ous, et al.
The Journal of Urology
|
February 1, 1991
Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
H L Qvist, S D Fosså, S Ous, et al.
Cancer
|
November 15, 1993
Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients
S D Fosså, H Waehre, N Aass, et al.
The Journal of Urology
|
January 1, 1992
The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy
A B Jacobsen, E O Pettersen, O Amellem, et al.
Pathology, Research and Practice
|
June 1, 1986
DNA flow cytometry in human bladder carcinoma
S D Fosså, E Thorud, E O Pettersen, et al.
British Journal of Urology
|
April 1, 1990
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
N Aass, S D Fosså, S Ous, et al.
European Urology
|
January 1, 1984
Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I
S D Fosså, O Klepp, S Ous, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 1, 1990
Prognosis in patients with metastatic non-seminomatous testicular cancer
N Aass, S D Fosså, S Ous, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
July 1, 1988
Computed tomography of invasive bladder carcinoma after diagnostic transurethral resection
E M Sager, K Talle, L Lindsköld, et al.
Scandinavian Journal of Urology and Nephrology
|
January 1, 1984
Multi-modality treatment of advanced malignant germ cell tumours in males. I. Experience with cis-platinum-based combination chemotherapy
O Klepp, S D Fosså, S Ous, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Journal of Surgical Oncology
|
August 1, 1992
Retroperitoneal surgery in patients with nonseminomatous testicular cancer and minimal residual tumor
H Qvist, S D Fosså, S Ous, et al.
The Journal of Urology
|
February 1, 1991
Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
H L Qvist, S D Fosså, S Ous, et al.
Cancer
|
November 15, 1993
Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients
S D Fosså, H Waehre, N Aass, et al.
The Journal of Urology
|
January 1, 1992
The prognostic significance of deoxyribonucleic acid flow cytometry in muscle invasive bladder carcinoma treated with preoperative irradiation and cystectomy
A B Jacobsen, E O Pettersen, O Amellem, et al.
Pathology, Research and Practice
|
June 1, 1986
DNA flow cytometry in human bladder carcinoma
S D Fosså, E Thorud, E O Pettersen, et al.
British Journal of Urology
|
April 1, 1990
Is routine primary retroperitoneal lymph node dissection still justified in patients with low stage non-seminomatous testicular cancer?
N Aass, S D Fosså, S Ous, et al.
European Urology
|
January 1, 1984
Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I
S D Fosså, O Klepp, S Ous, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 1, 1990
Prognosis in patients with metastatic non-seminomatous testicular cancer
N Aass, S D Fosså, S Ous, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
July 1, 1988
Computed tomography of invasive bladder carcinoma after diagnostic transurethral resection
E M Sager, K Talle, L Lindsköld, et al.
Scandinavian Journal of Urology and Nephrology
|
January 1, 1984
Multi-modality treatment of advanced malignant germ cell tumours in males. I. Experience with cis-platinum-based combination chemotherapy
O Klepp, S D Fosså, S Ous, et al.
Page
of 7